Erin Wright
Stock Analyst at Morgan Stanley
(2.94)
# 1,634
Out of 5,182 analysts
255
Total ratings
70%
Success rate
29.73%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MOH Molina Healthcare | Maintains: Equal-Weight | $158 → $128 | $149.98 | -14.66% | 4 | Mar 4, 2026 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $40 → $48 | $46.03 | +4.28% | 5 | Mar 4, 2026 | |
| HSIC Henry Schein | Maintains: Underweight | $58 → $61 | $75.99 | -19.73% | 6 | Feb 25, 2026 | |
| ELAN Elanco Animal Health | Maintains: Equal-Weight | $22 → $24 | $23.86 | +0.59% | 13 | Feb 25, 2026 | |
| PSX Phillips 66 | Maintains: Equal-Weight | $140 → $147 | $160.40 | -8.35% | 3 | Feb 5, 2026 | |
| ALGN Align Technology | Maintains: Equal-Weight | $154 → $169 | $180.67 | -6.46% | 26 | Feb 5, 2026 | |
| HUM Humana | Downgrades: Underweight | $262 → $174 | $198.23 | -12.22% | 6 | Feb 2, 2026 | |
| COR Cencora | Upgrades: Overweight | $361 → $400 | $319.12 | +25.34% | 2 | Jan 29, 2026 | |
| CAH Cardinal Health | Maintains: Overweight | $224 → $245 | $214.18 | +14.39% | 13 | Jan 29, 2026 | |
| OPCH Option Care Health | Maintains: Overweight | $35 → $38 | $28.93 | +31.35% | 2 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $359 → $352 | $316.07 | +11.37% | 5 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $89 → $93 | $78.09 | +19.09% | 7 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $211 → $175 | $120.08 | +45.74% | 8 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $857 → $916 | $864.57 | +5.95% | 10 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $765 → $805 | $574.00 | +40.24% | 19 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $26.91 | -36.83% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $59.58 | -56.36% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $390 | $275.12 | +41.76% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $2.30 | +39.13% | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $12.02 | +91.35% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $192.91 | -10.84% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $313.00 | +87.54% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $264.18 | +13.56% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $8.18 | +413.45% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $195.87 | +47.04% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $178.34 | +97.38% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $3.06 | +1,337.91% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $501.23 | -63.89% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $81.67 | -79.18% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $25.36 | +377.13% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $514.23 | +12.79% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $5.79 | +504.49% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $110.37 | +85.74% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $15.30 | -28.10% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $171.99 | -8.72% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $619.69 | -50.30% | 1 | Oct 25, 2017 |
Molina Healthcare
Mar 4, 2026
Maintains: Equal-Weight
Price Target: $158 → $128
Current: $149.98
Upside: -14.66%
BrightSpring Health Services
Mar 4, 2026
Maintains: Overweight
Price Target: $40 → $48
Current: $46.03
Upside: +4.28%
Henry Schein
Feb 25, 2026
Maintains: Underweight
Price Target: $58 → $61
Current: $75.99
Upside: -19.73%
Elanco Animal Health
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $22 → $24
Current: $23.86
Upside: +0.59%
Phillips 66
Feb 5, 2026
Maintains: Equal-Weight
Price Target: $140 → $147
Current: $160.40
Upside: -8.35%
Align Technology
Feb 5, 2026
Maintains: Equal-Weight
Price Target: $154 → $169
Current: $180.67
Upside: -6.46%
Humana
Feb 2, 2026
Downgrades: Underweight
Price Target: $262 → $174
Current: $198.23
Upside: -12.22%
Cencora
Jan 29, 2026
Upgrades: Overweight
Price Target: $361 → $400
Current: $319.12
Upside: +25.34%
Cardinal Health
Jan 29, 2026
Maintains: Overweight
Price Target: $224 → $245
Current: $214.18
Upside: +14.39%
Option Care Health
Jan 13, 2026
Maintains: Overweight
Price Target: $35 → $38
Current: $28.93
Upside: +31.35%
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $359 → $352
Current: $316.07
Upside: +11.37%
Dec 10, 2025
Maintains: Overweight
Price Target: $89 → $93
Current: $78.09
Upside: +19.09%
Nov 10, 2025
Maintains: Overweight
Price Target: $211 → $175
Current: $120.08
Upside: +45.74%
Nov 6, 2025
Maintains: Overweight
Price Target: $857 → $916
Current: $864.57
Upside: +5.95%
Nov 4, 2025
Maintains: Overweight
Price Target: $765 → $805
Current: $574.00
Upside: +40.24%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $26.91
Upside: -36.83%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $59.58
Upside: -56.36%
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $275.12
Upside: +41.76%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $2.30
Upside: +39.13%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $12.02
Upside: +91.35%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $192.91
Upside: -10.84%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $313.00
Upside: +87.54%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $264.18
Upside: +13.56%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $8.18
Upside: +413.45%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $195.87
Upside: +47.04%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $178.34
Upside: +97.38%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $3.06
Upside: +1,337.91%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $501.23
Upside: -63.89%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $81.67
Upside: -79.18%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $25.36
Upside: +377.13%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $514.23
Upside: +12.79%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $5.79
Upside: +504.49%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $110.37
Upside: +85.74%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $15.30
Upside: -28.10%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $171.99
Upside: -8.72%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $619.69
Upside: -50.30%